Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Syndax Pharmaceuticals (SNDX) Q3 2024 Earnings
SNDX
1
Aug
Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1
-0.91
-0.82
-0.73
Details
Expected EPS
-0.910767
Actual EPS
-0.8
Surprise EPS
0.11
Surprise Percent
+12.16%
Description
Syndax Pharmaceuticals (SNDX) has reported earnings of -0.8 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login